Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants

We studied 97 patients who developed cytomegalovirus (CMV) viremia following an allogeneic hemopoietic stem cell transplant (HSCT) between 2010 and 2015, treated with foscarnet, with the aim of assessing efficacy and safety. The donor was unrelated in 30 patients (UD) and a family HLA-haploidentical...

Descripción completa

Detalles Bibliográficos
Autores principales: Metafuni, Elisabetta, Chiusolo, Patrizia, Sica, Simona, Laurenti, Luca, Bregante, Stefania, Van Lint, Maria Teresa, Dominietto, Alida, Angelucci, Emanuele, Bacigalupo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281566/
https://www.ncbi.nlm.nih.gov/pubmed/29795416
http://dx.doi.org/10.1038/s41409-018-0200-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281566/
https://www.ncbi.nlm.nih.gov/pubmed/29795416
http://dx.doi.org/10.1038/s41409-018-0200-y

Ejemplares similares